PAREXEL Launches Perceptive MyTrials Data-Driven Monitoring
PAREXEL announced the launch of its Perceptive MyTrials Data-Driven Monitoring solution.
PAREXEL announced the launch of its Perceptive MyTrials® Data-Driven Monitoring solution. Developed by PAREXEL Informatics, it is a key component of its Perceptive MyTrials eClinical platform, an integrated suite of applications for managing clinical trials.
Perceptive MyTrials Data-Driven Monitoring an centralized monitoring approach that uses clinical data to guide monitoring activities as an alternative to periodically scheduled monitoring visits. This data can drive decision-making in determining when on-site monitoring visits need to occur and what activities should be undertaken during those visits. Monitoring focused on specific risks offers the potential to enhance patient safety, reduce costs and promote regulatory compliance.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
